12/26
06:59 am
cmnd
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
High
Report
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
12/24
07:14 am
cmnd
Clearmind Medicine receives IRB approval for Phase I/IIa clinical trial of CMND-100 [Seeking Alpha]
High
Report
Clearmind Medicine receives IRB approval for Phase I/IIa clinical trial of CMND-100 [Seeking Alpha]
12/24
06:59 am
cmnd
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial [Yahoo! Finance]
High
Report
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial [Yahoo! Finance]
12/24
06:55 am
cmnd
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
High
Report
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
12/16
08:37 am
cmnd
Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format
High
Report
Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format
10/10
08:15 am
cmnd
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site [Yahoo! Finance]
Medium
Report
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site [Yahoo! Finance]
10/10
08:07 am
cmnd
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
Low
Report
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site